Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1

Rosette-forming glioneuronal tumor (RGNT) is a rare brain neoplasm that primarily affects young adults. Although alterations affecting the mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K) signaling pathway have been associated with this low-grade entity, comprehensive mol...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Sievers, Philipp (VerfasserIn) , Schrimpf, Daniel (VerfasserIn) , Stichel, Damian (VerfasserIn) , Reuss, David (VerfasserIn) , Wefers, Annika K. (VerfasserIn) , Sahm, Felix (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 27 June 2019
In: Acta neuropathologica
Year: 2019, Jahrgang: 138, Heft: 3, Pages: 497-504
ISSN:1432-0533
DOI:10.1007/s00401-019-02038-4
Online-Zugang:Verlag, Volltext: https://doi.org/10.1007/s00401-019-02038-4
Volltext
Verfasserangaben:Philipp Sievers, Romain Appay, Daniel Schrimpf, Damian Stichel, David E. Reuss, Annika K. Wefers, Annekathrin Reinhardt, Roland Coras, Viktoria C. Ruf, Simone Schmid, Karin de Stricker, Henning B. Boldt, Bjarne Winther Kristensen, Jeanette Krogh Petersen, Benedicte P. Ulhøi, Maria Gardberg, Eleonora Aronica, Martin Hasselblatt, Wolfgang Brück, Franck Bielle, Karima Mokhtari, Benoît Lhermitte, Wolfgang Wick, Christel Herold-Mende, Daniel Hänggi, Sebastian Brandner, Felice Giangaspero, David Capper, Elisabeth Rushing, Pieter Wesseling, Stefan M. Pfister, Dominique Figarella-Branger, Andreas von Deimling, Felix Sahm, David T.W. Jones

MARC

LEADER 00000caa a2200000 c 4500
001 1677536594
003 DE-627
005 20230427002345.0
007 cr uuu---uuuuu
008 190923s2019 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00401-019-02038-4  |2 doi 
035 |a (DE-627)1677536594 
035 |a (DE-599)KXP1677536594 
035 |a (OCoLC)1341244277 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Sievers, Philipp  |e VerfasserIn  |0 (DE-588)1075154790  |0 (DE-627)832941514  |0 (DE-576)443264953  |4 aut 
245 1 0 |a Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1  |c Philipp Sievers, Romain Appay, Daniel Schrimpf, Damian Stichel, David E. Reuss, Annika K. Wefers, Annekathrin Reinhardt, Roland Coras, Viktoria C. Ruf, Simone Schmid, Karin de Stricker, Henning B. Boldt, Bjarne Winther Kristensen, Jeanette Krogh Petersen, Benedicte P. Ulhøi, Maria Gardberg, Eleonora Aronica, Martin Hasselblatt, Wolfgang Brück, Franck Bielle, Karima Mokhtari, Benoît Lhermitte, Wolfgang Wick, Christel Herold-Mende, Daniel Hänggi, Sebastian Brandner, Felice Giangaspero, David Capper, Elisabeth Rushing, Pieter Wesseling, Stefan M. Pfister, Dominique Figarella-Branger, Andreas von Deimling, Felix Sahm, David T.W. Jones 
264 1 |c 27 June 2019 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 23.09.2019 
520 |a Rosette-forming glioneuronal tumor (RGNT) is a rare brain neoplasm that primarily affects young adults. Although alterations affecting the mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K) signaling pathway have been associated with this low-grade entity, comprehensive molecular investigations of RGNT in larger series have not been performed to date, and an integrated view of their genetic and epigenetic profiles is still lacking. Here we describe a genome-wide DNA methylation and targeted sequencing-based characterization of a molecularly distinct class of tumors (n = 30), initially identified through genome-wide DNA methylation screening among a cohort of > 30,000 tumors, of which most were diagnosed histologically as RGNT. FGFR1 hotspot mutations were observed in all tumors analyzed, with co-occurrence of PIK3CA mutations in about two-thirds of the cases (63%). Additional loss-of-function mutations in the tumor suppressor gene NF1 were detected in a subset of cases (33%). Notably, in contrast to most other low-grade gliomas, these tumors often displayed co-occurrence of two or even all three of these mutations. Our data highlight that molecularly defined RGNTs are characterized by highly recurrent combined genetic alterations affecting both MAPK and PI3K signaling pathways. Thus, these two pathways appear to synergistically interact in the formation of RGNT, and offer potential therapeutic targets for this disease. 
650 4 |a Brain tumor 
650 4 |a DNA methylation profile 
650 4 |a FGFR1 
650 4 |a MAPK 
650 4 |a Molecular classification 
650 4 |a NF1 
650 4 |a PI3K 
650 4 |a PIK3CA 
650 4 |a RGNT 
650 4 |a Rosette-forming glioneuronal tumor 
700 1 |a Schrimpf, Daniel  |d 1984-  |e VerfasserIn  |0 (DE-588)1063355044  |0 (DE-627)812332032  |0 (DE-576)422629529  |4 aut 
700 1 |a Stichel, Damian  |e VerfasserIn  |0 (DE-588)1078124507  |0 (DE-627)838010059  |0 (DE-576)359423566  |4 aut 
700 1 |a Reuss, David  |d 1976-  |e VerfasserIn  |0 (DE-588)143839837  |0 (DE-627)655107894  |0 (DE-576)339294337  |4 aut 
700 1 |a Wefers, Annika K.  |d 1982-  |e VerfasserIn  |0 (DE-588)1110221673  |0 (DE-627)864827938  |0 (DE-576)475754077  |4 aut 
700 1 |a Sahm, Felix  |d 1984-  |e VerfasserIn  |0 (DE-588)1022852132  |0 (DE-627)717318478  |0 (DE-576)366075020  |4 aut 
773 0 8 |i Enthalten in  |t Acta neuropathologica  |d Berlin : Springer, 1961  |g 138(2019), 3, Seite 497-504  |h Online-Ressource  |w (DE-627)253389666  |w (DE-600)1458410-4  |w (DE-576)072283092  |x 1432-0533  |7 nnas  |a Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1 
773 1 8 |g volume:138  |g year:2019  |g number:3  |g pages:497-504  |g extent:8  |a Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1 
856 4 0 |u https://doi.org/10.1007/s00401-019-02038-4  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20190923 
993 |a Article 
994 |a 2019 
998 |g 1022852132  |a Sahm, Felix  |m 1022852132:Sahm, Felix  |d 910000  |d 912000  |e 910000PS1022852132  |e 912000PS1022852132  |k 0/910000/  |k 1/910000/912000/  |p 34 
998 |g 1110221673  |a Wefers, Annika K.  |m 1110221673:Wefers, Annika K.  |d 910000  |d 912000  |e 910000PW1110221673  |e 912000PW1110221673  |k 0/910000/  |k 1/910000/912000/  |p 6 
998 |g 143839837  |a Reuss, David  |m 143839837:Reuss, David  |d 910000  |d 912000  |e 910000PR143839837  |e 912000PR143839837  |k 0/910000/  |k 1/910000/912000/  |p 5 
998 |g 1078124507  |a Stichel, Damian  |m 1078124507:Stichel, Damian  |d 700000  |d 716000  |e 700000PS1078124507  |e 716000PS1078124507  |k 0/700000/  |k 1/700000/716000/  |p 4 
998 |g 1063355044  |a Schrimpf, Daniel  |m 1063355044:Schrimpf, Daniel  |d 910000  |d 912000  |e 910000PS1063355044  |e 912000PS1063355044  |k 0/910000/  |k 1/910000/912000/  |p 3 
998 |g 1075154790  |a Sievers, Philipp  |m 1075154790:Sievers, Philipp  |d 910000  |d 910100  |e 910000PS1075154790  |e 910100PS1075154790  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1677536594  |e 3517315273 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"eki":["1677536594"],"doi":["10.1007/s00401-019-02038-4"]},"name":{"displayForm":["Philipp Sievers, Romain Appay, Daniel Schrimpf, Damian Stichel, David E. Reuss, Annika K. Wefers, Annekathrin Reinhardt, Roland Coras, Viktoria C. Ruf, Simone Schmid, Karin de Stricker, Henning B. Boldt, Bjarne Winther Kristensen, Jeanette Krogh Petersen, Benedicte P. Ulhøi, Maria Gardberg, Eleonora Aronica, Martin Hasselblatt, Wolfgang Brück, Franck Bielle, Karima Mokhtari, Benoît Lhermitte, Wolfgang Wick, Christel Herold-Mende, Daniel Hänggi, Sebastian Brandner, Felice Giangaspero, David Capper, Elisabeth Rushing, Pieter Wesseling, Stefan M. Pfister, Dominique Figarella-Branger, Andreas von Deimling, Felix Sahm, David T.W. Jones"]},"recId":"1677536594","physDesc":[{"extent":"8 S."}],"title":[{"title":"Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1","title_sort":"Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1"}],"note":["Gesehen am 23.09.2019"],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"origin":[{"publisher":"Springer","publisherPlace":"Berlin ; Heidelberg","dateIssuedKey":"1961","dateIssuedDisp":"1961-"}],"pubHistory":["1.1961/62 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng","ger"],"note":["Gesehen am 02.12.2005"],"id":{"eki":["253389666"],"issn":["1432-0533"],"zdb":["1458410-4"]},"title":[{"title_sort":"Acta neuropathologica","title":"Acta neuropathologica"}],"part":{"extent":"8","text":"138(2019), 3, Seite 497-504","issue":"3","pages":"497-504","volume":"138","year":"2019"},"physDesc":[{"extent":"Online-Ressource"}],"recId":"253389666","disp":"Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1Acta neuropathologica"}],"person":[{"display":"Sievers, Philipp","given":"Philipp","role":"aut","family":"Sievers"},{"family":"Schrimpf","role":"aut","given":"Daniel","display":"Schrimpf, Daniel"},{"display":"Stichel, Damian","role":"aut","given":"Damian","family":"Stichel"},{"display":"Reuss, David","family":"Reuss","given":"David","role":"aut"},{"display":"Wefers, Annika K.","given":"Annika K.","role":"aut","family":"Wefers"},{"display":"Sahm, Felix","family":"Sahm","role":"aut","given":"Felix"}],"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"27 June 2019"}]} 
SRT |a SIEVERSPHIROSETTEFOR2720